chr16:69740899:> Detail (hg19)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr16:69,740,899-69,760,571 |
| hg38 | chr16:69,706,996-69,726,668 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
| Score | Disease name | Description | Source | Pubmed | Links |
|---|---|---|---|---|---|
| <0.001 | renal cell carcinoma | NA | BeFree | Detail | |
| 0.019 | squamous cell carcinoma | The additive effect of smoking and the NQO1 C-T/C-T diplotype was more apparent ... | BeFree,GAD,LHGDN | 25729241 | Detail |
| 0.019 | squamous cell carcinoma | The NQO1 protein showed a mainly cytoplasmic staining pattern in lung cancer cel... | BeFree,GAD,LHGDN | 25880877 | Detail |
| <0.001 | Cardiovascular Diseases | NA | BeFree | Detail | |
| 0.002 | Neoplastic Cell Transformation | NA | GAD | Detail | |
| 0.002 | intracranial aneurysm | NA | GAD | Detail | |
| 0.001 | Malignant tumor of cervix | NA | BeFree | Detail | |
| 0.005 | Uterine Cervical Neoplasm | NA | GAD | Detail | |
| 0.120 | cholestasis | NA | CTD_human | Detail | |
| 0.005 | Chromosome Aberrations | NA | GAD | Detail | |
| <0.001 | Congenital chromosomal disease | This study was conducted to determine the association between arsenic exposure a... | BeFree | 25395496 | Detail |
| <0.001 | colitis | NA | BeFree | Detail | |
| 0.003 | ulcerative colitis | NA | BeFree,GAD | Detail | |
| 0.080 | Colonic Neoplasms | NA | BeFree,RGD | Detail | |
| 0.004 | colorectal carcinoma | NA | BeFree | Detail | |
| 0.132 | Colorectal Neoplasms | NA | BeFree,CTD_human,GAD | Detail | |
| <0.001 | Coronary Arteriosclerosis | NA | BeFree | Detail | |
| 0.003 | Coronary heart disease | NA | BeFree,GAD | Detail | |
| 0.120 | contact dermatitis | NA | CTD_human | Detail | |
| <0.001 | Diabetes | NA | BeFree | Detail | |
| <0.001 | diabetes mellitus | NA | BeFree | Detail | |
| 0.120 | Diabetes Mellitus, Experimental | NA | CTD_human | Detail | |
| 0.003 | Diabetes Mellitus, Insulin-Dependent | NA | BeFree,GAD | Detail | |
| 0.008 | Diabetes Mellitus, Non-Insulin-Dependent | NA | BeFree,GAD | Detail | |
| 0.005 | DNA Damage | NA | GAD | Detail | |
| <0.001 | Drug abuse | NA | BeFree | Detail | |
| 0.005 | Dyskinetic syndrome | NA | GAD,LHGDN | Detail | |
| <0.001 | endometriosis | NA | BeFree | Detail | |
| 0.009 | Esophageal Neoplasms | NA | BeFree,GAD | Detail | |
| <0.001 | esophagitis | NA | BeFree | Detail | |
| <0.001 | Exanthema | NA | BeFree | Detail | |
| 0.080 | Fatty Liver | NA | RGD | Detail | |
| 0.002 | Fetal Growth Retardation | NA | GAD | Detail | |
| <0.001 | gastroesophageal reflux disease | NA | BeFree | Detail | |
| <0.001 | glioblastoma | NA | BeFree | Detail | |
| 0.017 | Head and Neck Neoplasms | NA | GAD | Detail | |
| <0.001 | Heart Diseases | NA | BeFree | Detail | |
| 0.002 | Heart failure | NA | GAD | Detail | |
| <0.001 | congestive heart failure | NA | BeFree | Detail | |
| 0.120 | hemolytic-uremic syndrome | NA | CTD_human | Detail | |
| <0.001 | Herpes Simplex Infections | NA | BeFree | Detail | |
| 0.002 | Hodgkin Disease | NA | GAD | Detail | |
| 0.120 | hyperglycemia | NA | CTD_human | Detail | |
| <0.001 | Hypertensive disease | The aim of this study was to examine the individual and interactive associations... | BeFree | 25529925 | Detail |
| 0.002 | male infertility | NA | GAD | Detail | |
| <0.001 | ischemia | NA | BeFree | Detail | |
| 0.120 | Kidney Diseases | NA | CTD_human | Detail | |
| 0.005 | Laryngeal neoplasm | NA | GAD | Detail | |
| 0.024 | leukemia | NA | BeFree,GAD,LHGDN | Detail | |
| 0.007 | chronic lymphocytic leukemia | NA | BeFree,GAD | Detail | |
| 0.004 | Acute lymphocytic leukemia | NA | BeFree | Detail | |
| 0.011 | Leukemia, Lymphocytic, Acute, L1 | NA | BeFree,GAD | Detail | |
| 0.022 | Leukemia, Myelocytic, Acute | NA | BeFree,GAD,LHGDN | Detail | |
| 0.128 | myeloid leukemia | NA | BeFree,CTD_human,GAD | Detail | |
| 0.003 | Myeloid Leukemia, Chronic | NA | BeFree,GAD | Detail | |
| 0.120 | Liver diseases | NA | CTD_human | Detail | |
| 0.003 | Liver neoplasms | NA | BeFree,GAD | Detail | |
| <0.001 | Lung diseases | NA | BeFree | Detail | |
| 0.005 | Chronic Obstructive Airway Disease | NA | GAD | Detail | |
| 0.013 | Lung Neoplasms | NA | BeFree,GAD,LHGDN | Detail | |
| 0.003 | lymphoma | NA | BeFree,GAD | Detail | |
| 0.009 | Lymphoma, Non-Hodgkin | NA | GAD | Detail | |
| 0.001 | Malignant neoplasm of stomach | NA | BeFree | Detail | |
| 0.002 | Marijuana Abuse | NA | GAD | Detail | |
| <0.001 | melanoma | NA | BeFree | Detail | |
| <0.001 | Mesothelioma | NA | BeFree | Detail | |
| <0.001 | Metabolic Diseases | Our data suggest that polymorphisms of HMOX1 and NQO1 genes are associated with ... | BeFree | 25933176 | Detail |
| 0.002 | Metaplasia | NA | GAD | Detail | |
| <0.001 | mitral valve stenosis | NA | BeFree | Detail | |
| 0.005 | Mouth Neoplasms | NA | GAD | Detail | |
| 0.126 | multiple myeloma | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
| <0.001 | multiple sclerosis | Combined GSTP1 and NQO1 germline polymorphisms in the susceptibility to Multiple... | BeFree | 24588223 | Detail |
| <0.001 | Myeloproliferative disease | NA | BeFree | Detail | |
| 0.002 | myocardial infarction | NA | GAD | Detail | |
| 0.001 | Neoplasm Metastasis | Clinically, overexpression of the NFE2L2 target gene NQO1 in tumours was signifi... | BeFree | 25135868 | Detail |
| 0.002 | Neoplasm Recurrence, Local | NA | GAD | Detail | |
| 0.120 | Neoplasms, Experimental | NA | CTD_human | Detail | |
| 0.001 | neuroblastoma | NA | BeFree | Detail | |
| <0.001 | Spots on skin | Genotyping for glutathione S-transferase micro1 (GSTM1), glutathione S-transfera... | BeFree | 14716779 | Detail |
| <0.001 | Nevus | NA | BeFree | Detail | |
| <0.001 | Exanthema | Genotyping for glutathione S-transferase micro1 (GSTM1), glutathione S-transfera... | BeFree | 14716779 | Detail |
| <0.001 | Melanocytic nevus | NA | BeFree | Detail | |
| 0.120 | obesity | NA | CTD_human | Detail | |
| 0.125 | Occupational Diseases | NA | CTD_human,GAD | Detail | |
| 0.001 | ovarian carcinoma | High expression of NQO1 is associated with poor prognosis in serous ovarian carc... | BeFree | 25885439 | Detail |
| 0.006 | Pancreatic Neoplasm | NA | BeFree,LHGDN | Detail | |
| 0.120 | papilloma | NA | CTD_human | Detail | |
| 0.139 | Parkinson disease | NA | CTD_human,GAD,LHGDN | Detail | |
| 0.002 | Peritoneal Neoplasms | NA | GAD | Detail | |
| 0.005 | Pharyngeal Neoplasms | NA | GAD | Detail | |
| 0.002 | Pregnancy Complications | NA | GAD | Detail | |
| <0.001 | Preleukemia | NA | BeFree | Detail | |
| 0.005 | Prenatal Exposure Delayed Effects | NA | GAD | Detail | |
| 0.123 | Prostatic Neoplasms | NA | BeFree,CTD_human,LHGDN | Detail | |
| 0.002 | psoriasis | NA | GAD | Detail | |
| 0.002 | Psychoses, Substance-Induced | NA | GAD | Detail | |
| 0.009 | schizophrenia | NA | BeFree,GAD,LHGDN | Detail | |
| 0.080 | Seizures | NA | RGD | Detail | |
| <0.001 | Septicemia | NA | BeFree | Detail | |
| 0.002 | Stomach Neoplasms | NA | GAD | Detail | |
| 0.003 | Cerebrovascular accident | NA | BeFree,GAD | Detail | |
| 0.080 | Subarachnoid Hemorrhage | NA | RGD | Detail | |
| <0.001 | synovial sarcoma | NA | BeFree | Detail | |
| 0.002 | Thyroid Neoplasm | NA | GAD | Detail | |
| 0.002 | Trisomy | NA | GAD | Detail | |
| <0.001 | Unipolar Depression | NA | BeFree | Detail | |
| 0.080 | ureteral obstruction | NA | RGD | Detail | |
| 0.002 | varicocele | NA | GAD | Detail | |
| <0.001 | vitiligo | NA | BeFree | Detail | |
| 0.005 | Helicobacter Infections | NA | GAD | Detail | |
| 0.003 | diffuse large B-cell lymphoma | NA | BeFree,GAD | Detail | |
| 0.002 | T-Cell Lymphoma | NA | GAD | Detail | |
| 0.002 | Bronchial Hyperreactivity | NA | GAD | Detail | |
| 0.005 | Neoplasms, Second Primary | NA | GAD | Detail | |
| 0.001 | acute leukemia | NA | BeFree | Detail | |
| 0.002 | Alcohol abuse | NA | GAD | Detail | |
| 0.004 | Small cell carcinoma of lung | In conclusion, NQO1 plays an important role in the progression of SCLC, and it m... | BeFree,LHGDN | 25231218 | Detail |
| 0.002 | Premature Birth | NA | GAD | Detail | |
| 0.002 | Adenocarcinoma of lung (disorder) | NA | BeFree | Detail | |
| 0.002 | esophageal carcinoma | NA | BeFree | Detail | |
| 0.001 | lingual-facial-buccal dyskinesia | NA | BeFree | Detail | |
| 0.005 | Malignant neoplasm of brain | NA | GAD | Detail | |
| <0.001 | Tumor Progression | This study attempted to explore the role of NQO1 in tumor progression and progno... | BeFree | 25880877 | Detail |
| 0.001 | hepatoblastoma | NA | BeFree | Detail | |
| <0.001 | cholangiocarcinoma | NA | BeFree | Detail | |
| <0.001 | Melanoma, Amelanotic | NA | BeFree | Detail | |
| <0.001 | adult brain tumor | NA | BeFree | Detail | |
| <0.001 | diastrophic dysplasia | NA | BeFree | Detail | |
| 0.120 | Neurotoxicity Syndromes | NA | CTD_human | Detail | |
| <0.001 | pancreatic carcinoma | NA | BeFree | Detail | |
| <0.001 | Alcohol withdrawal syndrome | NA | BeFree | Detail | |
| 0.002 | Cancer of Nasopharynx | NA | GAD | Detail | |
| <0.001 | Papillary thyroid carcinoma | NA | BeFree | Detail | |
| 0.060 | Malignant neoplasm of lung | Interactive effect of smoking and NQO1 haplotypes on lung cancer risk. | BeFree,GAD | 25729241 | Detail |
| 0.060 | Malignant neoplasm of lung | The NQO1 protein showed a mainly cytoplasmic staining pattern in lung cancer cel... | BeFree,GAD | 25880877 | Detail |
| 0.002 | Oxidative Stress | NA | GAD | Detail | |
| <0.001 | Sepsis | NA | BeFree | Detail | |
| 0.003 | Childhood asthma | NA | BeFree,GAD | Detail | |
| <0.001 | Gastric dysplasia | NA | BeFree | Detail | |
| <0.001 | gastric adenocarcinoma | NA | BeFree | Detail | |
| <0.001 | Malignant Childhood Neoplasm | NA | BeFree | Detail | |
| <0.001 | Small cell lung cancer limited stage | Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in... | BeFree | 25400754 | Detail |
| 0.004 | Squamous cell carcinoma of esophagus | NA | BeFree,GAD | Detail | |
| <0.001 | Adenocarcinoma Of Esophagus | NA | BeFree | Detail | |
| <0.001 | cervical squamous cell carcinoma | NA | BeFree | Detail | |
| 0.001 | Solid tumour | High expression of NQO1 is associated with many solid tumors including those aff... | BeFree | 25885439 | Detail |
| <0.001 | Adenocarcinoma of pancreas | NA | BeFree | Detail | |
| 0.001 | cervix carcinoma | NA | BeFree | Detail | |
| <0.001 | Restenosis | NA | BeFree | Detail | |
| 0.002 | Atrophic | NA | GAD | Detail | |
| 0.002 | Malignant neoplasm of liver | NA | GAD | Detail | |
| <0.001 | Malignant neoplasm of pancreas | NA | BeFree | Detail | |
| <0.001 | Aplastic anemia, idiopathic | NA | BeFree | Detail | |
| <0.001 | Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | NA | BeFree | Detail | |
| 0.009 | Malignant neoplasm of prostate | These results reveal a molecular link between NQO1 expression and proinflammator... | BeFree,GAD | 25125658 | Detail |
| <0.001 | Hematologic Neoplasms | NA | BeFree | Detail | |
| <0.001 | Non-alcoholic Fatty Liver Disease | NA | BeFree | Detail | |
| <0.001 | Chromosome 8, trisomy | NA | BeFree | Detail | |
| 0.002 | neuropathy | NA | GAD | Detail | |
| 0.003 | urolithiasis | NA | BeFree,GAD | Detail | |
| 0.005 | Mood Disorders | NA | BeFree,GAD,LHGDN | Detail | |
| 0.011 | Malignant neoplasm of esophagus | NA | BeFree,GAD | Detail | |
| <0.001 | Thyroid carcinoma | quinone oxidoreductase-1 (NQO1) is commonly elevated in various types of human c... | BeFree | 25231218 | Detail |
| 0.004 | Carcinogenesis | NQO1 suppresses NF-κB-p300 interaction to regulate inflammatory mediators associ... | BeFree | 25125658 | Detail |
| <0.001 | Leukemogenesis | NA | BeFree | Detail | |
| 0.002 | prostate carcinoma | These results reveal a molecular link between NQO1 expression and proinflammator... | BeFree | 25125658 | Detail |
| 0.002 | Manganese Poisoning | NA | GAD | Detail | |
| <0.001 | Epithelial ovarian cancer | High expression of NQO1 is associated with poor prognosis in serous ovarian carc... | BeFree | 25885439 | Detail |
| 0.007 | breast carcinoma | NQO1 expression variations in human breast cancer patient samples were noted, wh... | BeFree | 24512128 | Detail |
| 0.007 | breast carcinoma | Relationship of MTHFR and NQO1 Pharmacogenetics and Chemotherapy Clinical Outcom... | BeFree | 26014925 | Detail |
| 0.008 | Carcinoma of lung | Interactive effect of smoking and NQO1 haplotypes on lung cancer risk. | BeFree | 25729241 | Detail |
| 0.008 | Carcinoma of lung | The NQO1 protein showed a mainly cytoplasmic staining pattern in lung cancer cel... | BeFree | 25880877 | Detail |
| <0.001 | Malignant neoplasm of gastrointestinal tract | NA | BeFree | Detail | |
| 0.001 | Tardive Dyskinesia | NA | BeFree | Detail | |
| <0.001 | Secondary malignant neoplasm of lymph node | The rate of strong positive NQO1 protein expression was correlated with large tu... | BeFree | 25231218 | Detail |
| <0.001 | Secondary malignant neoplasm of lymph node | The positive rate of NQO1 was related with clinical stage and lymph node metasta... | BeFree | 25880877 | Detail |
| 0.003 | colon carcinoma | NA | BeFree | Detail | |
| 0.002 | stomach carcinoma | NA | BeFree | Detail | |
| 0.001 | Central neuroblastoma | NA | BeFree | Detail | |
| 0.080 | Infarction, Middle Cerebral Artery | NA | RGD | Detail | |
| <0.001 | Malignant neoplasm of kidney | NA | BeFree | Detail | |
| <0.001 | Premenopausal breast cancer | NA | BeFree | Detail | |
| <0.001 | biliary tract cancer | NA | BeFree | Detail | |
| <0.001 | Brain Tumor, Primary | NA | BeFree | Detail | |
| <0.001 | Spots on skin | NA | BeFree | Detail | |
| <0.001 | breast adenocarcinoma | NA | BeFree | Detail | |
| <0.001 | Carcinogenicity | NA | BeFree | Detail | |
| <0.001 | Ischemic stroke | NA | BeFree | Detail | |
| <0.001 | Bone marrow toxicity | NA | BeFree | Detail | |
| 0.002 | Papillomavirus Infections | NA | GAD | Detail | |
| 0.003 | Malignant neoplasm of ovary | NA | BeFree,GAD | Detail | |
| <0.001 | Squamous cell carcinoma of the head and neck | NA | BeFree | Detail | |
| <0.001 | Ductal Carcinoma | NA | BeFree | Detail | |
| 0.003 | major depressive disorder | NA | BeFree,LHGDN | Detail | |
| 0.001 | Adenoma of large intestine | NA | BeFree | Detail | |
| <0.001 | Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome | NA | BeFree | Detail | |
| <0.001 | childhood leukemia | NA | BeFree | Detail | |
| <0.001 | Carcinoma of urinary bladder, superficial | NA | BeFree | Detail | |
| <0.001 | renal carcinoma | NA | BeFree | Detail | |
| <0.001 | Benign melanocytic nevus | NA | BeFree | Detail | |
| 0.134 | Mammary Neoplasms | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
| <0.001 | Skin Carcinogenesis | NA | BeFree | Detail | |
| 0.034 | colorectal cancer | NA | BeFree,GAD | Detail | |
| <0.001 | Ductal Breast Carcinoma | NA | BeFree | Detail | |
| <0.001 | Benign Prostatic Hyperplasia | NA | BeFree | Detail | |
| 0.120 | SPINOCEREBELLAR ATAXIA 17 | NA | CTD_human | Detail | |
| <0.001 | VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding) | NA | BeFree | Detail | |
| 0.003 | coronary artery disease | NA | BeFree,GAD | Detail | |
| 0.159 | Precursor Cell Lymphoblastic Leukemia Lymphoma | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
| 0.008 | liver carcinoma | Association between the NQO1 C609T polymorphism with hepatocellular carcinoma ri... | BeFree,GAD,LHGDN | 25773831 | Detail |
| <0.001 | Treatment related leukaemia | NA | BeFree | Detail | |
| <0.001 | Ischemic Cerebrovascular Accident | NA | BeFree | Detail | |
| 0.005 | myelodysplastic syndrome | NA | BeFree,GAD | Detail | |
| <0.001 | Triple Negative Breast Neoplasms | Tumor-selective, futile redox cycle-induced bystander effects elicited by NQO1 b... | BeFree | 24512128 | Detail |
| <0.001 | Experimental Organism Basal Cell Carcinoma | NA | BeFree | Detail | |
| 0.015 | adenocarcinoma | NA | BeFree,GAD,LHGDN | Detail | |
| 0.016 | adenoma | NA | BeFree,GAD,LHGDN | Detail | |
| 0.010 | Alzheimer's disease | NA | BeFree,GAD | Detail | |
| <0.001 | anemia | We found significant association of variant genotype (TT) of NQO1 609C>T with gr... | BeFree | 26014925 | Detail |
| <0.001 | aplastic anemia | NA | BeFree | Detail | |
| 0.002 | Aneuploidy | NA | GAD | Detail | |
| 0.002 | Angina Pectoris | NA | GAD | Detail | |
| <0.001 | arteriosclerosis | NA | BeFree | Detail | |
| 0.136 | asthma | NA | BeFree,CTD_human,GAD | Detail | |
| 0.003 | atherosclerosis | NA | BeFree,GAD | Detail | |
| 0.003 | Balkan nephropathy | NA | BeFree,GAD | Detail | |
| 0.003 | Barrett esophagus | NA | BeFree,LHGDN | Detail | |
| <0.001 | Benign Ovarian Neoplasm | NQO1 protein expression was assessed using immunohistochemical (IHC) staining in... | BeFree | 25885439 | Detail |
| 0.131 | Bladder Neoplasm | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
| <0.001 | Brain Neoplasms | NA | BeFree | Detail | |
| 0.036 | Malignant neoplasm of breast | NQO1 expression variations in human breast cancer patient samples were noted, wh... | BeFree,GAD | 24512128 | Detail |
| 0.036 | Malignant neoplasm of breast | Relationship of MTHFR and NQO1 Pharmacogenetics and Chemotherapy Clinical Outcom... | BeFree,GAD | 26014925 | Detail |
| <0.001 | bronchopulmonary dysplasia | In regression models that adjusted for epidemiological confounders, the NQO1 and... | BeFree | 25518008 | Detail |
| 0.008 | Burkitt lymphoma | NA | GAD,LHGDN | Detail | |
| <0.001 | Malignant tumor of colon | NA | BeFree | Detail | |
| <0.001 | Adenocarcinoma of prostate | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of skin | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of thyroid | quinone oxidoreductase-1 (NQO1) is commonly elevated in various types of human c... | BeFree | 25231218 | Detail |
| <0.001 | Noninfiltrating Intraductal Carcinoma | NA | BeFree | Detail | |
| 0.124 | Non-small cell lung carcinoma | The NQO1 C609T polymorphism is an important molecular marker for advanced NSCLC,... | BeFree,CTD_human | 24464627 | Detail |
| 0.124 | Non-small cell lung carcinoma | Increased NQO1 but not c-MET and survivin expression in non-small cell lung carc... | BeFree,CTD_human | 25222473 | Detail |
| 0.124 | Non-small cell lung carcinoma | NQO1 protein expression predicts poor prognosis of non-small cell lung cancers. | BeFree,CTD_human | 25880877 | Detail |
| 0.002 | Carcinoma, Papillary | NA | GAD | Detail |
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| NA | DisGeNET | Detail |
| The additive effect of smoking and the NQO1 C-T/C-T diplotype was more apparent in squamous cell car... | DisGeNET | Detail |
| The NQO1 protein showed a mainly cytoplasmic staining pattern in lung cancer cells, including adenoc... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| This study was conducted to determine the association between arsenic exposure and polymorphisms of ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The aim of this study was to examine the individual and interactive associations of five non-synonym... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Our data suggest that polymorphisms of HMOX1 and NQO1 genes are associated with a high risk of metab... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Combined GSTP1 and NQO1 germline polymorphisms in the susceptibility to Multiple Sclerosis. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Clinically, overexpression of the NFE2L2 target gene NQO1 in tumours was significantly associated wi... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Genotyping for glutathione S-transferase micro1 (GSTM1), glutathione S-transferase theta1 (GSTT1), m... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Genotyping for glutathione S-transferase micro1 (GSTM1), glutathione S-transferase theta1 (GSTT1), m... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In conclusion, NQO1 plays an important role in the progression of SCLC, and it may potentially be us... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| This study attempted to explore the role of NQO1 in tumor progression and prognostic evaluation of n... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Interactive effect of smoking and NQO1 haplotypes on lung cancer risk. | DisGeNET | Detail |
| The NQO1 protein showed a mainly cytoplasmic staining pattern in lung cancer cells, including adenoc... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| High expression of NQO1 is associated with many solid tumors including those affecting the colon, br... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| These results reveal a molecular link between NQO1 expression and proinflammatory cytokine signaling... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| quinone oxidoreductase-1 (NQO1) is commonly elevated in various types of human cancers, including pa... | DisGeNET | Detail |
| NQO1 suppresses NF-κB-p300 interaction to regulate inflammatory mediators associated with prostate t... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| These results reveal a molecular link between NQO1 expression and proinflammatory cytokine signaling... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma. | DisGeNET | Detail |
| NQO1 expression variations in human breast cancer patient samples were noted, where ~60% cancers ove... | DisGeNET | Detail |
| Relationship of MTHFR and NQO1 Pharmacogenetics and Chemotherapy Clinical Outcomes in Breast Cancer ... | DisGeNET | Detail |
| Interactive effect of smoking and NQO1 haplotypes on lung cancer risk. | DisGeNET | Detail |
| The NQO1 protein showed a mainly cytoplasmic staining pattern in lung cancer cells, including adenoc... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The rate of strong positive NQO1 protein expression was correlated with large tumor size (P=0.019), ... | DisGeNET | Detail |
| The positive rate of NQO1 was related with clinical stage and lymph node metastasis, and the strongl... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Association between the NQO1 C609T polymorphism with hepatocellular carcinoma risk in the Chinese po... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Tumor-selective, futile redox cycle-induced bystander effects elicited by NQO1 bioactivatable radios... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We found significant association of variant genotype (TT) of NQO1 609C>T with grade 2-4 toxicity [OR... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NQO1 protein expression was assessed using immunohistochemical (IHC) staining in 160 patients with s... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NQO1 expression variations in human breast cancer patient samples were noted, where ~60% cancers ove... | DisGeNET | Detail |
| Relationship of MTHFR and NQO1 Pharmacogenetics and Chemotherapy Clinical Outcomes in Breast Cancer ... | DisGeNET | Detail |
| In regression models that adjusted for epidemiological confounders, the NQO1 and the NFE2L2 SNPs wer... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| quinone oxidoreductase-1 (NQO1) is commonly elevated in various types of human cancers, including pa... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The NQO1 C609T polymorphism is an important molecular marker for advanced NSCLC, since it is associa... | DisGeNET | Detail |
| Increased NQO1 but not c-MET and survivin expression in non-small cell lung carcinoma with KRAS muta... | DisGeNET | Detail |
| NQO1 protein expression predicts poor prognosis of non-small cell lung cancers. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- dbSNP
- rs386493716 dbSNP
- Genome
- hg19
- Position
- chr16:69,740,899-69,760,571
- Variant Type
- snv
Genome browser